Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.41% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Mar 31, 2025
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-25-024342General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
33.28% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
37.84% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
34.99% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
87.83% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
11.03% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.06% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.63% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.18%
- Current
- 0.41%
- Delta
- 0.23%
- Previous
- -1.62%
- Current
- 33.28%
- Delta
- 34.90%
- Previous
- -4.26%
- Current
- 37.84%
- Delta
- 42.10%
- Previous
- 10.56%
- Current
- 34.99%
- Delta
- 24.43%
- Previous
- 82.61%
- Current
- 87.83%
- Delta
- 5.22%
- Previous
- -16.99%
- Current
- 11.03%
- Delta
- 28.02%
- Previous
- 12.72%
- Current
- 11.06%
- Delta
- -1.66%
- Previous
- 0.80%
- Current
- 0.63%
- Delta
- -0.16%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_INCREASED →Transitioned To · CPIX CASH_GENERATION_INCREASED →Transitioned To · CPIX GROWTH_INCREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_INCREASED →Transitioned To · CPIX PROFITABILITY_INCREASED →Transitioned To · CPIX R_AND_D_INTENSITY_DECREASED →Transitioned To · CPIX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.